Addex Therapeutics: Neuer Wirkstoff gegen Angstzustände bei Depression macht Fortschritte (Seite 2)
eröffnet am 11.10.12 18:06:16 von
neuester Beitrag 12.04.24 11:16:38 von
neuester Beitrag 12.04.24 11:16:38 von
Beiträge: 103
ID: 1.177.220
ID: 1.177.220
Aufrufe heute: 1
Gesamt: 21.240
Gesamt: 21.240
Aktive User: 0
ISIN: US00654J2069 · WKN: A3EXC6 · Symbol: APE1
20,000
EUR
-28,06 %
-7,800 EUR
Letzter Kurs 19.04.24 Frankfurt
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
3,5800 | +922,86 | |
0,8800 | +95,56 | |
2.000,00 | +71,23 | |
29,10 | +21,25 | |
0,9650 | +14,88 |
Wertpapier | Kurs | Perf. % |
---|---|---|
9,7200 | -19,60 | |
1,5000 | -24,62 | |
14,510 | -32,32 | |
3,6400 | -38,62 | |
0,7000 | -61,85 |
Beitrag zu dieser Diskussion schreiben
moin moin ... ist hier noch wer drin ausser mir?
Addex Reports Q3 2020 Financial Results and Provides Corporate Update Nachrichtenquelle: globenewswire | 03.11.2020, 07:00 | 117 | 0 | 0 Geneva, Switzerland, November 3, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its third quarter financial results and provided an update on corporate activities. “We continue to execute on our strategy to advance our portfolio of in-house discovered allosteric modulator programs and have made significant progress, with three programs scheduled to start clinical studies in Q1 2021, and a robust pipeline of preclinical programs advancing towards the clinic,” said Tim Dyer CEO of Addex. “Our GABAB PAM program is on track to deliver clinical candidates in 2021 and as announced yesterday we have received renewed support from our partner, Indivior. This is a tremendous position to be in and we are looking forward to achieving these important milestones.”
Addex Reports Q3 2020 Financial Results and Provides Corporate Update | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/13106432-addex-re…
Addex Reports Q3 2020 Financial Results and Provides Corporate Update Nachrichtenquelle: globenewswire | 03.11.2020, 07:00 | 117 | 0 | 0 Geneva, Switzerland, November 3, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its third quarter financial results and provided an update on corporate activities. “We continue to execute on our strategy to advance our portfolio of in-house discovered allosteric modulator programs and have made significant progress, with three programs scheduled to start clinical studies in Q1 2021, and a robust pipeline of preclinical programs advancing towards the clinic,” said Tim Dyer CEO of Addex. “Our GABAB PAM program is on track to deliver clinical candidates in 2021 and as announced yesterday we have received renewed support from our partner, Indivior. This is a tremendous position to be in and we are looking forward to achieving these important milestones.”
Addex Reports Q3 2020 Financial Results and Provides Corporate Update | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/13106432-addex-re…
ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020 Nachrichtenquelle: globenewswire | 02.11.2020, 07:06 | 101 | 0 | 0 Geneva, Switzerland, November 2, 2020 – Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, will discuss its Q3 2020 financial results, provide a business update and review its pipeline during a teleconference and webcast for investors, analysts and the media on Tuesday, November 3, 2020 at 16:00 CET (15:00 GMT/10:00 ET). Title: Addex Q3 2020 Financial Results Conference Call Date: November 3, 2020 Time: 16:00 CEST (15:00 GMT/10:00 ET)
ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020 | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/13100858-addex-th…
ADDEX THERAPEUTICS TO RELEASE Q3 2020 FINANCIAL RESULTS AND HOST CONFERENCE CALL ON NOVEMBER 3rd, 2020 | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/13100858-addex-th…
Addex Therapeutics to Participate at the H.C. Wainwright 22nd Annual Global Investment Conference Nachrichtenquelle: globenewswire | 14.09.2020, 07:00 | 101 | 0 | 0 Geneva, Switzerland, September 14, 2020 - Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development today announced that Tim Dyer, Chief Executive Officer, is scheduled to participate at the Virtual H.C. Wainwright 22nd Annual Global Investment Conference taking place on September 14 – September 16, 2020. Mr. Dyer will participate and present Addex on September 15, 2020 at 16:30 EDT / 22:30 CEST. You can follow the event by following this link.
Addex Therapeutics to Participate at the H.C. Wainwright 22nd Annual Global Investment Conference | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12925027-addex-th…
Addex Therapeutics to Participate at the H.C. Wainwright 22nd Annual Global Investment Conference | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12925027-addex-th…
Antwort auf Beitrag Nr.: 64.858.934 von aldy78 am 24.08.20 09:49:58Bin auch noch als Überleber hier übrig geblieben 😂
Stecke seit gut einem Jahr hier fest....
So langsam geht es aber bergauf 👌
Stecke seit gut einem Jahr hier fest....
So langsam geht es aber bergauf 👌
moin moin ... addex zittert sich zittrig nach oben ... ist hier noch jemand drin oder muss ich mich alleine hier unterhalten? good luck!
Addex Reports 2020 Half Year Financial Results and Provides Corporate Update Nachrichtenquelle: globenewswire | 12.08.2020, 07:00 | 111 | 0 | 0 Geneva, Switzerland, August 12, 2020 – Addex Therapeutics (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today reported its second quarter and half year financial results for the periods ended June 30, 2020 and provided an update on corporate activities.
Addex Reports 2020 Half Year Financial Results and Provides Corporate Update | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12824746-addex-re…
Addex Reports 2020 Half Year Financial Results and Provides Corporate Update | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12824746-addex-re…
Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020 Nachrichtenquelle: globenewswire | 06.08.2020, 07:00 | 84 | 0 | 0 Geneva, Switzerland, August 6, 2020 - Addex Therapeutics Ltd (SIX and Nasdaq: ADXN), a leading company pioneering allosteric modulation-based drug discovery and development, today announced that Tim Dyer, Chief Executive Officer, will participate in the BTIG Virtual Biotechnology Conference taking place on August 10 – 11, 2020. Mr. Dyer will participate and present Addex on August 10, 2020 at 10:30 AM ET. You can follow the event by following this link.
Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020 | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12805393-addex-th…
Addex Therapeutics to Participate in the BTIG Virtual Biotechnology Conference 2020 | wallstreet-online.de - Vollständiger Artikel unter:
https://www.wallstreet-online.de/nachricht/12805393-addex-th…
Antwort auf Beitrag Nr.: 62.805.479 von manffreddoo am 27.02.20 12:28:49Da hast du wohl recht, wird Zeit das die amis mit mischen können, steht ja alles da nur nicht handelbar. Leider auch kein Datum ab wann es los geht nur irgendwas mit 11$ steht da 😂das wäre ja was!
Antwort auf Beitrag Nr.: 62.789.093 von urpferdchen am 26.02.20 07:34:48Hi Ur,
hält sich angesichts der Marktlage verdammt gut.......wei lange noch?......bis A. ausbricht
M.
hält sich angesichts der Marktlage verdammt gut.......wei lange noch?......bis A. ausbricht
M.